Organoids Market Scope And Analysis

  • Report Code : TIPRE00017616
  • Category : Life Sciences
  • Status : Published
  • No. of Pages : 297
Buy Now

Organoids Market Analysis, Trends, and Scope 2023 to 2030

Buy Now

Organoids Market Report Organoids Market Size and Share Organoids Market Scope and Analysis

Organoids Market Report Scope

Report Attribute Details
Market size in 2023 US$ 3.03 Billion
Market Size by 2031 US$ 15.01 Billion
Global CAGR (2023 - 2031) 22.3%
Historical Data 2021-2022
Forecast period 2024-2031
Segments Covered By Type
  • Intestine
  • Liver
  • Stomach
  • Pancreas
  • Lung
  • Brain
  • Kidney
By Application
  • Developmental Biology Disease
  • Pathology of Infectious Disease
  • Regenerative Medicine
  • Drug Toxicity & Efficacy Testing
  • Drug Discovery & Personalized Medicine
By Source
  • Pluripotent Stem Cells
  • Organ Specific Adult Stem Cell
By Offering
  • Instruments
  • Consumables
  • Services
Regions and Countries Covered North America
  • US
  • Canada
  • Mexico
Europe
  • UK
  • Germany
  • France
  • Russia
  • Italy
  • Rest of Europe
Asia-Pacific
  • China
  • India
  • Japan
  • Australia
  • Rest of Asia-Pacific
South and Central America
  • Brazil
  • Argentina
  • Rest of South and Central America
Middle East and Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Rest of Middle East and Africa
Market leaders and key company profiles
  • Sino Biological Inc
  • Eurofins Scientific SE
  • Molecular Devices LLC
  • InSphero
  • Cyprio InnoSer
  • LABTOO
  • CUSABIO TECHNOLOGY LLC
  • Oncodesign Services
  • HUB Organoids B V Hubrecht Organoid Technology

    • Organoids Market News and Recent Developments

    The organoids market is evaluated by gathering qualitative and quantitative data post primary and secondary research, which includes important corporate publications, association data, and databases. A few of the developments in the market are listed below:

    • InSphero, a biotech company, signed a partnership agreement with Genome Biologics, Frankfurt. In this partnership, InSphero will receive the exclusive global rights to commercialize Genome Biologics' 3D Cardiac Organoid Platform. The platform provides accurate, scalable, and disease-specific organoid models for creating novel treatments, placing it at the forefront of heart disease research. (InSphero, Press Release, May 2024)

    Organoids Market Report Coverage and Deliverables

    The "Organoids Market Size and Forecast (2021–2031)" report provides a detailed analysis of the market covering below areas:

    • Organoids market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
    • Organoids market trends as well as market dynamics such as drivers, restraints, and key opportunities
    • Detailed PEST/Porter's Five Forces and SWOT analysis
    • Organoids market analysis covering key market trends, global and regional framework, major players, regulations, and recent market developments.
    • Industry landscape and competition analysis covering market concentration, heat map analysis, prominent players, and recent developments for the Organoids market
    • Detailed company profiles